NCT07653555

Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP

Not Yet Recruiting
NAAges 1+Interventional
Mayo Clinic
~480 participants
Updated 2026-06-17 on ClinicalTrials.gov
What's tested:Cascade testingStandard of Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Genetic testing among first- and second-degree relatives within 12 months of index patient enrollment
Measured over 2 year
Familial Hypercholesterolemia
1 sites across 1 states
Minnesota1
  • Elisa J. Houwink, MD, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Family Medicine Research Study Coordinators
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years.
Confirmed FH diagnosis using Dutch Lipid Clinic Network criteria \*or\* genetic confirmation.
Identified through REP or Tapestry databases.
Able and willing to provide informed consent.
At least one eligible first- or second-degree relative.
Access to and active use of email (computer literacy requirement).
First- or second-degree relative of an enrolled index patient.
Age ≥ 1 year (minors require parental consent + assent).
Willing to participate and able to complete electronic consent (guardian-assisted if minor).
Access to and active use of email (guardian).

Exclusion

No confirmed FH diagnosis.
Insufficient clinical follow-up (\<5 years).
No identifiable or contactable relatives.
Prior participation in structured cascade testing.
Severe cognitive impairment preventing informed consent.
Prior participation in structured cascade testing.
Severe cognitive impairment preventing informed consent.
  • Genetic testing among first- and second-degree relatives within 12 months of index patient enrollment2 year

    Defined as total number of relations to complete CLIA-certified FH test (LDLR, APOB, PCSK9, LDLRAP1) with result returned to the primary care research team.